Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanoch Miodownik

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Neuropharmacology|January 6, 2011
Efficacy of bupropion XR in treatment-resistant elderly patients: a case series studyJoseph Bergman, Chanoch Miodownik, Alex Palatnik, et al.
Clinical Neuropharmacology|June 2, 2009
Moclobemide treatment of clozapine-induced hypersalivation: pilot open studyAnatoly Kreinin, Chanoch Miodownik, Igor Libov, et al.
The Journal of Clinical Psychiatry|September 13, 2006
The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled studyChanoch Miodownik, Vladimir Lerner, Adi Kibari, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover studyIgor Libov, Chanoch Miodownik, Yuly Bersudsky, et al.
Clinical Neuropharmacology|March 30, 2005
Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapyVladimir Lerner, Joseph Bergman, Alexander Borokhov, et al.
Journal of Clinical Psychopharmacology|January 27, 2023
Treatment of Clozapine-Associated Sialorrhea: The Role of Benzamide DerivativesChanoch Miodownik, Anatoly Kreinin, Paul P Lerner, et al.
Clinical Neuropharmacology|February 3, 2007
High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary studyChanoch Miodownik, Vladimir Lerner, Tali Vishne, et al.
Clinical Neuropharmacology|January 13, 2015
Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case seriesChanoch Miodownik, Joseph Bergman, Paul P Lerner, et al.
The Journal of Clinical Psychiatry|February 13, 2002
Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled studyVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 12, 2005
Vitamin B12 and folate serum levels in newly admitted psychiatric patientsVladimir Lerner, Michael Kanevsky, Tzvi Dwolatzky, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Neuropharmacology|January 6, 2011
Efficacy of bupropion XR in treatment-resistant elderly patients: a case series studyJoseph Bergman, Chanoch Miodownik, Alex Palatnik, et al.
Clinical Neuropharmacology|June 2, 2009
Moclobemide treatment of clozapine-induced hypersalivation: pilot open studyAnatoly Kreinin, Chanoch Miodownik, Igor Libov, et al.
The Journal of Clinical Psychiatry|September 13, 2006
The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled studyChanoch Miodownik, Vladimir Lerner, Adi Kibari, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover studyIgor Libov, Chanoch Miodownik, Yuly Bersudsky, et al.
Clinical Neuropharmacology|March 30, 2005
Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapyVladimir Lerner, Joseph Bergman, Alexander Borokhov, et al.
Journal of Clinical Psychopharmacology|January 27, 2023
Treatment of Clozapine-Associated Sialorrhea: The Role of Benzamide DerivativesChanoch Miodownik, Anatoly Kreinin, Paul P Lerner, et al.
Clinical Neuropharmacology|February 3, 2007
High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary studyChanoch Miodownik, Vladimir Lerner, Tali Vishne, et al.
Clinical Neuropharmacology|January 13, 2015
Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case seriesChanoch Miodownik, Joseph Bergman, Paul P Lerner, et al.
The Journal of Clinical Psychiatry|February 13, 2002
Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled studyVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 12, 2005
Vitamin B12 and folate serum levels in newly admitted psychiatric patientsVladimir Lerner, Michael Kanevsky, Tzvi Dwolatzky, et al.
Pageof 4